Back to Feed
ClinicalTrials.gov|Clinical Trial
The Effect of CB-Exo-A600 in Mild to Moderate Alzheimer's Disease
Xuanwu Hospital, Beijing
Abstract
This study is divided into two phases: a dose-escalation phase and an expansion cohort phase. The dose-escalation phase is a single-center study, while the expansion cohort phase is a multicenter, prospective, randomized, double-blind, placebo-controlled study. Phase: PHASE1, PHASE2 Status: NOT_YET_RECRUITING Conditions: Mild to Moderate Alzheimer's Disease Interventions: Exosomes derived from umbilical cord mesenchymal stem cell for intranasal drop; A placebo of exosomes derived from umbilical cord mesenchymal stem cell for intranasal drop
Keywords
Mild to Moderate Alzheimer's Disease